Kadmon Holdings, Inc. (KDMN): Price and Financial Metrics
KDMN Price/Volume Stats
Current price | $9.50 | 52-week high | $9.50 |
Prev. close | $9.48 | 52-week low | $3.19 |
Day low | $9.48 | Volume | 10,424,500 |
Day high | $9.50 | Avg. volume | 5,109,463 |
50-day MA | $8.58 | Dividend yield | N/A |
200-day MA | $5.34 | Market Cap | 1.70B |
KDMN Stock Price Chart Interactive Chart >
Kadmon Holdings, Inc. (KDMN) Company Bio
Kadmon Holdings, LLC discovers, develops, and commercializes small molecules and biologics to address unmet medical needs. The company markets and distributes a portfolio of branded generic ribavirin products for chronic hepatitis C virus infection; co-promotes a product for chronic weight management; distributes products for chorea, cytomegalovirus retinitis, and for the prevention of CMV disease. The company is based in New York City, New York
KDMN Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | 127.82% |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | 0.00% |
2020 | -8.39% |
2019 | 117.79% |
Continue Researching KDMN
Here are a few links from around the web to help you further your research on Kadmon Holdings Inc's stock as an investment opportunity:Kadmon Holdings Inc (KDMN) Stock Price | Nasdaq
Kadmon Holdings Inc (KDMN) Stock Quote, History and News - Yahoo Finance
Kadmon Holdings Inc (KDMN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...